PNC FINANCIAL SERVICES GROUP, INC. - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 169 filers reported holding GW PHARMACEUTICALS PLC in Q4 2016. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$115,000
-12.2%
530
-53.1%
0.00%
Q4 2020$131,000
+52.3%
1,130
+27.0%
0.00%
Q3 2020$86,000
-27.1%
890
-6.9%
0.00%
Q2 2020$118,000
+53.2%
956
+7.4%
0.00%
Q1 2020$77,000
+14.9%
890
+39.1%
0.00%
Q4 2019$67,000
+86.1%
640
+103.2%
0.00%
Q3 2019$36,000
-50.0%
315
-24.1%
0.00%
Q2 2019$72,000
-10.0%
415
-12.3%
0.00%
Q1 2019$80,000
+196.3%
473
+68.9%
0.00%
Q4 2018$27,000
-64.9%
280
-37.1%
0.00%
Q3 2018$77,000
+71.1%
445
+39.1%
0.00%
Q2 2018$45,000
+73.1%
320
+39.1%
0.00%
Q1 2018$26,000
-18.8%
230
-8.4%
0.00%
Q4 2017$32,000
+39.1%
251
+9.1%
0.00%
Q3 2017$23,0000.0%2300.0%0.00%
Q2 2017$23,000
-17.9%
2300.0%0.00%
Q1 2017$28,000
+86.7%
230
+76.9%
0.00%
Q4 2016$15,000
-48.3%
130
-40.1%
0.00%
Q3 2016$29,000
+141.7%
217
+66.9%
0.00%
Q2 2016$12,000
+33.3%
1300.0%0.00%
Q1 2016$9,000
-18.2%
130
-18.8%
0.00%
Q4 2015$11,000
-8.3%
160
+23.1%
0.00%
Q3 2015$12,000
-98.5%
130
-98.0%
0.00%
-100.0%
Q2 2015$814,000
+31.3%
6,630
-2.6%
0.00%0.0%
Q1 2015$620,000
+45.2%
6,807
+7.9%
0.00%
Q4 2014$427,000
+130.8%
6,307
+175.4%
0.00%
Q3 2014$185,000
+115.1%
2,290
+186.2%
0.00%
Q2 2014$86,0008000.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2016
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders